Nucleos(t)ide Analogue (NA): Clinical Trials

2 trials of Nucleos(t)ide Analogue (NA), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Not yet recruiting 1, Recruiting 1

Follow Nucleos(t)ide Analogue (NA): new trials by email Literature Review of Nucleos(t)ide Analogue (NA) trials Research Report on Nucleos(t)ide Analogue (NA)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of AHB-171 in Chronic Hepatitis B Participants
AHB-171, Placebo matching [Investigational Product], Nucleos(t)ide Analogue (NA) - Hepatitis B, Chronic
Phase 1Not yet recruitingAusperBio Therapeutics Inc.1442026-07-062026-06-01
A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants
AHB-171 Injection, Placebo, Nucleos(t)ide Analogue (NA) - Chronic Hepatitis B Infection
Phase 1RecruitingAusper Biopharma Co., Ltd.1102026-04-132026-07-21

Conditions studied

Hepatitis B, Chronic (2)

Sponsors

Ausper Biopharma Co., Ltd. (1)  ·  AusperBio Therapeutics Inc. (1)

Countries

China (1)  ·  Hong Kong (1)  ·  New Zealand (1)